Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.75%
#2 0G 0G +29.50%
#3 SAFEcoin SAFEcoin +27.44%
#4 Seeker Seeker +23.54%
#5 Pons Pons +21.03%
#6 Zora Zora +20.06%
#7 VVS Finance VVS Finance +18.18%
#8 Full Moon Full Moon +17.70%
#9 Axelar Axelar +17.50%
#10 Concordium Concordium +17.01%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Classifica tra le azioni #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Prezzo delle azioni
$4.99
Capitalizzazione di mercato
$508.03M
Variazione (1 giorno)
-2.48%
Variazione (1 anno)
2.10%
Paese
TW
Scambia Ever Supreme Bio Technology Co., Ltd (6712)

Categoria

Healthcare
Rapporto P/B per Ever Supreme Bio Technology Co., Ltd (6712)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Ever Supreme Bio Technology Co., Ltd, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Ever Supreme Bio Technology Co., Ltd da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH